Verification evidence is still being completed.
PDF / print export
Genomtec S.A.
Wroclaw, Poland
- Verified lead
- Miron Tokarski
- Lead status
- STATUS: VERIFIED APRIL 2026
- Leadership verification
- Chief Executive Officer and Co-Founder
- 2026 technical specialization
- Point-of-Care Isothermal Molecular Diagnostics and SNAAT-Based Cartridge Devices
- Review cycle
- 24 April 2026
- Full address
- ul. Bierutowska 57-59, 51-317 Wroclaw, Poland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Genomtec About Us page naming Miron Tokarski as CEO and Co-founder.
- Editorial note
- Wroclaw WSE-listed (GMT) point-of-care molecular diagnostics developer with named co-founder CEO, isothermal SNAAT platform, and CE-IVD device pipeline.
Point-of-Care Isothermal Molecular Diagnostics and SNAAT-Based Cartridge Devices
WSE GMT listing, CE-IVD pipeline, Public co-founder CEO disclosure
Wroclaw WSE-listed (GMT) point-of-care molecular diagnostics developer with named co-founder CEO, isothermal SNAAT platform, and CE-IVD device pipeline.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Wroclaw, Poland
Genomtec S.A.
Point-of-Care Isothermal Molecular Diagnostics and SNAAT-Based Cartridge Devices · POC diagnostic device development
Wroclaw WSE-listed (GMT) point-of-care molecular diagnostics developer with named co-founder CEO, isothermal SNAAT platform, and CE-IVD device pipeline.
- Lead
- Miron Tokarski (verified ↗)
- Address
- ul. Bierutowska 57-59, 51-317 Wroclaw, Poland (source ↗)
- Compliance
- CE-IVD pipeline
- Last reviewed
- 24 Apr 2026 (1mo ago)
- Scale
- POC diagnostic device development
- Capabilities
- Isothermal Nucleic Acid Amplification · Cartridge-Based POC Devices · Respiratory and Infectious Disease Panels
- Founded
- 2016
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED APRIL 2026
Miron Tokarski
Chief Executive Officer and Co-Founder
Full addressul. Bierutowska 57-59, 51-317 Wroclaw, Poland
Site coordinatesVerification evidence is still being completed.
Review cycle24 April 2026
Physical site source
NorthData KRS registry entry for Genomtec listing Bierutowska 57-59 in Wroclaw.
Open sourcePOC diagnostic device development
Wroclaw, Poland. Point-of-Care Isothermal Molecular Diagnostics and SNAAT-Based Cartridge Devices. Review completed on 24 Apr 2026.
Polish Health Ministry and EU IVDR for medical-device oversight
WSE GMT listing, CE-IVD pipeline, Public co-founder CEO disclosure
Point-of-Care Isothermal Molecular Diagnostics and SNAAT-Based Cartridge Devices
Wroclaw WSE-listed (GMT) point-of-care molecular diagnostics developer with named co-founder CEO, isothermal SNAAT platform, and CE-IVD device pipeline.
Editorial note
Genomtec is a WSE-listed (GMT) point-of-care molecular diagnostics developer with a named co-founder CEO and an isothermal SNAAT amplification platform targeting CE-IVD respiratory and infectious-disease panels.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleApril 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Isothermal Nucleic Acid Amplification
Cartridge-Based POC Devices
Respiratory and Infectious Disease Panels
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
SNAAT amplification platform
Cartridge device engineering
CE-IVD validation workflow
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- VERIFIED ACTIVE 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
24 Apr 2026: Executive identity confirmed via official management disclosure.
24 Apr 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Genomtec S.A. located?
- Genomtec S.A. operates from ul. Bierutowska 57-59, 51-317 Wroclaw, Poland, Wroclaw, Poland.
- Who runs Genomtec S.A.?
- Genomtec S.A. is led by Miron Tokarski, Chief Executive Officer and Co-Founder. Verified 24 Apr 2026.
- What certifications does Genomtec S.A. hold?
- Genomtec S.A. is documented under CE-IVD pipeline.
- What does Genomtec S.A. do?
- Wroclaw WSE-listed (GMT) point-of-care molecular diagnostics developer with named co-founder CEO, isothermal SNAAT platform, and CE-IVD device pipeline. Core capabilities: Isothermal Nucleic Acid Amplification, Cartridge-Based POC Devices, Respiratory and Infectious Disease Panels.
Editorial context
Related technical briefs
Briefs that name Wroclaw as a covered market or city.